Vsevolod Katritch

机构：QB3, University of Southern California, California Southern University, Biologie Computationnelle, Quantitative et Synthétique, Convergent Science (United States), Drug Discovery Laboratory (Norway), Southern States University · ORCID：0000-0003-3883-4505

发表论文 253 篇 · 总被引 29782 次 · h-index 78

代表论文

• Structural insights into the high basal activity and inverse agonism of the orphan receptor GPR6 implicated in Parkinson’s disease (2024 · Science Signaling · 被引 22)
• Oxa-Iboga alkaloids lack cardiac risk and disrupt opioid use in animal models (2024 · Nature Communications · 被引 20)
• Navigating structure-based drug discovery with emerging innovations in physics- and knowledge-based approaches (2025 · npj Drug Discovery. · 被引 19)
• Development of Calcium-Dependent Phospholipase A2 Inhibitors to Target Cellular Senescence and Oxidative Stress in Neurodegenerative Diseases (2024 · Antioxidants and Redox Signaling · 被引 17)
• A bitopic agonist bound to the dopamine 3 receptor reveals a selectivity site (2024 · Nature Communications · 被引 16)
• Structure-guided design of partial agonists at an opioid receptor (2025 · Nature Communications · 被引 15)